Speakers

Meet the World-Class Speaker Faculty Driving Innovation in Ophthalmic Gene Therapy

Adam Turpcu, Adverum Biotechnologies

Adam Turpcu

SVP

Adverum Biotechnologies

Amy Christenson, Beacon Therapeutics

Amy Christenson

Executive Director, Medical Affairs Lead

Beacon Therapeutics

Arun Upadhyay, Ocugen

Arun Upadhyay

Chief Scientific Officer

Ocugen

Cherie Fathy, Alnylam Pharmaceuticals

Cherie Fathy

Director - Clinical Research

Alnylam Pharmaceuticals

Christina Ohnsman, Tern Therapeutics

Christina Ohnsman

CMO

Tern Therapeutics

Claire Gelfman, Independent Expert

Claire Gelfman

Scientific Advisor-Ophthalmology

Independent Expert

Darin Curtiss, Beacon Therapeutics

Darin Curtiss

Global Vice President - Clinical Development

Beacon Therapeutics

Dave MacLellan

Director of Downstream Marketing

iCare

James Kasuboski, Luma Group

James Kasuboski

Partner & Head of Research

Luma Group

Laura Pardon, Atsena Therapeutics

Laura Pardon

Associate Director, Clinical Development

Atsena Therapeutics

Mayur Choudhary

Mayur Choudhary

Director, Gene Therapy

Opus Genetics

Mike Schwartz from Sepul Bio joins the 6th Gene Therapy for Ophthalmic Disorders Summit

Mike Schwartz

COO

Sepul Bio

Molly Johnson

Molly Johnson

Senior Director Data Science

Avista Therapeutics

Moshe Weinstein, Everads Therapy Ltd

Moshe Weinstein

Executive Chairman

Everads-Therapy

Philip Beales, Axovia Therapeutics

Phil Beales

CEO

Axovia Therapeutics

Randall Wong, 4D Molecular Therapeutics

Randall Wong

Director

4D Molecular Therapeutics

Thomas Ciulla, Ikarovec

Thomas Ciulla

President & Chief Executive Officer

Ikarovec

Zhenghong Gao

Zhenghong Gao

Chief Strategy Officer

Zhongmou Therapeutics

Like the faculty and want to know more?
Discover their sessions in the full event program here

Register Today
Full Event Program
Partner With Us